Home » Topics » BioWorld Science

BioWorld Science
RSS

Fochon Pharmaceuticals patents Bcl-2 inhibitors

Nov. 22, 2021

NTX-1088, anti-PVR MAb with exclusive triple mechanism of action

Nov. 22, 2021

LINC01348 as a potential new therapeutic target and biomarker in HCC

Nov. 22, 2021

In vivo studies of HRX-0215 in acute and chronic liver disease

Nov. 22, 2021

ALP and LECT2 are markers of SZN-043 target engagement and Wnt pathway activation

Nov. 22, 2021

Neurons increase cholesterol synthesis during chronic myelin disease

Nov. 22, 2021

FAUST, a novel interpretable machine-learning method for unbiased discovery in single-cell cytometry

Nov. 19, 2021

Zika virus antagonism of mitophagy drives pathological proinflammatory chemokine expression

Nov. 19, 2021

Study offers insights into post-MI fibrosis

Nov. 19, 2021

Replication stress response defects signature predicts ICB response in nonhypermutated cancers

Nov. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...